Rock Springs Capital Management LP Spruce Biosciences, Inc. Call Options Transaction History
Rock Springs Capital Management LP
- $2.51 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SPRB
# of Institutions
32Shares Held
15.9MCall Options Held
0Put Options Held
0-
River Vest Venture Management LLC St. Louis, MO2.94MShares$1.12 Million20.39% of portfolio
-
Carlyle Group Inc. Washington, DC2.9MShares$1.1 Million1.19% of portfolio
-
Abingworth LLP London, X01.79MShares$681,1560.65% of portfolio
-
Acadian Asset Management LLC Boston, MA1.05MShares$397,4140.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX1MShares$380,0000.07% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $8.95M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...